Ashish Shah, DO
Enriched profileHematology and Medical Oncology physician (Advanced Care Oncology and Hematology) · Advanced Care Oncology and Hematology
Ashish Shah is Hematology and Medical Oncology physician (Advanced Care Oncology and Hematology) at Advanced Care Oncology and Hematology. ClinicalTrials.gov lists 6 registered studies with this person as an investigator.
Data verified 27 Oct 2026
Overview
Updated 1 Nov 2026
Ashish Ashvin Shah, D.O., is Hematology and Medical Oncology physician (Advanced Care Oncology and Hematology). It also documents an investigator role on 6 registered clinical trials, industry payments reported by 73 companies.
- Top research focus: Glioma
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 73 companies
Generated from the cited public record · current as of 1 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 1 Nov 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma
Sponsor: University of California, San Francisco
- STARLITE for Unresectable High-Grade Gliomas
Sponsor: University of Miami
Industry payments
Updated 1 Nov 2026
73 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202566 payments$59,538openpaymentsdata.cms.gov ↗
- E.R. Squibb & Sons, L.L.C.Program year202511 payments$14,244openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year202521 payments$11,931openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
39.9%BCL-2 Inhibitor30.4%Venclexta100%Part D<11 patientsAromatase Inhibitor9.5%Letrozole100%Part D<11 patientsMetabolism & gastrointestinal
35.1%Proton pump inhibitor18.9%Omeprazole100%Part D≥11 patientsSerotonin-3 Receptor Antagonist8.1%Ondansetron Hcl100%Part D≥11 patients+ 1 more class in this area
Anti-infectives
13.5%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor13.5%Valacyclovir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Background & recognition
Updated 1 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- DO
Philadelphia College of Osteopathic Medicine (medical school)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atlantichealth.org ↗
Editorial & leadership roles
journal and society appointments- Member
American Society of Clinical Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →atlantichealth.org ↗ - Member
American Society of Hematology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →atlantichealth.org ↗
Secondary affiliations
appointments beyond the home institution- Clinical assistant professor
University of South Florida (prior)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →atlantichealth.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Guy McKhann, MD
Emory University School of Medicine
Patrick Wen, MD
Dana-Farber Cancer Institute
Minesh Mehta, MD
Florida International University Herbert Wertheim College of Medicine
Timothy Cloughesy, MD
Ronald Reagan UCLA Medical Center